← All themes

Immunotherapy & Oncology

Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.

388 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
126	126 Lakefront Biotherapeutics American Depositary Shares LKFT $1.93B	76	-14	-16%	$960M
127	127 Oncolytics Biotech ONCY $70.6M	76	+17	+29%	$3.76M
128	128 Pyxis Oncology PYXS $149M	76	-2	-3%	$101M
129	129 OnKure Therapeutics OKUR $91.1M	75	+24	+47%	$159M
130	130 Prelude Therapeutics PRLD $258M	75	+20	+36%	$264M
131	131 Alpha Tau Medical DRTS $1.25B	74	+21	+40%	$100M
132	132 Artiva Biotherapeutics ARTV $289M	72	+32	+80%	$392M
133	133 Genelux GNLX $105M	72	+1	+1%	$29.5M
134	134 BridgeBio Oncology BBOT $233M	65	-2	-3%	$451M
135	135 iShares Genomics Immunology and Healthcare ETF IDNA $312M	65	+5	+8%	$85.8M
136	136 PMV Pharmaceuticals PMVP $66.3M	64	-5	-7%	$45.9M
137	137 Actuate Therapeutics ACTU $10.4M	63	+2	+3%	$20.7M
138	138 Anixa Biosciences ANIX $92.1M	63	+3	+5%	$15M
139	139 Telix Pharmaceuticals TLX $3.62B	61	+22	+56%	$36.6M
140	140 enGene Therapeutics ENGN $105M	60	-2	-3%	$86.5M
141	141 TScan Therapeutics TCRX $14.3M	60	0	0%	$35.1M
142	142 Greenwich LifeSciences GLSI $226M	57	-7	-11%	$39.6M
143	143 Tvardi Therapeutics TVRD $13.3M	57	-10	-15%	$4.24M
144	144 Adicet Bio ACET $45.8M	56	+7	+14%	$52.8M
145	145 HUTCHMED HCM $2.34B	56	+2	+4%	$46.5M
146	146 Fortress Biotech FBIO $63.4M	55	+3	+6%	$17.7M
147	147 GT Biopharma GTBP $11.2M	55	+15	+38%	$1.02M
148	148 PDS Biotechnology PDSB $102M	52	+11	+27%	$6.78M
149	149 NovaBridge Biosciences American Depositary Shares NBP $148M	49	+1	+2%	$48.1M
150	150 Cypherpunk Technologies Inc CYPH $282M	48	+8	+20%	$9.13M